Literature DB >> 3769161

Iodine 123-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia.

P L Kennedy, J R Corbett, P V Kulkarni, C L Wolfe, D E Jansen, C L Hansen, L M Buja, R W Parkey, J T Willerson.   

Abstract

In this study, we tested the hypothesis that myocardial ischemia induced by exercise in patients is associated with diminished metabolism and/or delayed clearance of an intravenously injected fatty acid, iodine 123-labeled phenylpentadecanoic acid (IPPA). Fifteen normal volunteers and 18 patients with significant coronary heart disease (CHD) received IPPA during exercise. In the patients with CHD, radionuclide ventriculograms were also obtained during exercise. The normal volunteers had relatively uniform initial left ventricular segmental IPPA activity after exercise and uniform IPPA clearance in the interval from 4 to 20 min immediately after exercise. In contrast, the patients with CHD had increased initial left ventricular segmental IPPA activity (63%, p less than .001) and delayed IPPA clearance (44%, p less than .01) in segments supplied by significantly narrowed coronary arteries. Based on analysis with the mean values +/- 1 SD for initial IPPA activity, clearance, or both in normal volunteers, the sensitivity and specificity of exercise IPPA scintigraphy for detecting CHD were 89% and 67%, respectively; when +/- 2 SD differences from the mean values in the normal volunteers were considered, the sensitivity and specificity were 72% and 100%, respectively. Among the total of 27 noninfarcted left ventricular segments supplied by significantly narrowed coronary arteries in the study patients, 26 (96%) had an abnormality (mean +/- 1 SD) of either initial IPPA activity or clearance compared with corresponding segments in the normal volunteers and/or with other left ventricular segments in the same image that were not supplied by significantly narrowed coronary arteries.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3769161     DOI: 10.1161/01.cir.74.5.1007

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

1.  Does myocardial free fatty acid metabolism predict subsequent mechanical dysfunction associated with cardiomyopathy?

Authors:  A J Sinusas
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

Review 2.  Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.

Authors:  A Syrota; P Jehenson
Journal:  Eur J Nucl Med       Date:  1991

3.  Prospective evaluation of thallium-201 reinjection in single-vessel coronary patients undergoing coronary bypass surgery.

Authors:  J Mester; I Kósa; G Lupkovics; N Gruber; M Lázár; G Kovács; L Csernay
Journal:  Eur J Nucl Med       Date:  1993-03

4.  Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study.

Authors:  J Kropp
Journal:  Eur J Nucl Med       Date:  1993-04

5.  Inhomogeneous exercise uptake and accelerated washout of a radioiodinated fatty acid analogue in syndrome X. A SPECT study of the left ventricle.

Authors:  M Walamies; M Koskinen; A Uusitalo; K Niemelä
Journal:  Int J Card Imaging       Date:  1994-06

6.  The metabolism of 15-p-[123I]-iodophenylpentadecanoic acid in a surgically induced canine model of regional ischemia.

Authors:  M P Hudon; D M Lyster; W R Jamieson; A K Qayumi; C Sartori; H Dougan
Journal:  Eur J Nucl Med       Date:  1990

7.  Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.

Authors:  Y Takeishi; J Chiba; S Abe; I Tonooka; A Komatani; H Tomoike
Journal:  Eur J Nucl Med       Date:  1992

8.  Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study.

Authors:  R Zimmermann; B Rauch; M Kapp; B Bubeck; F J Neumann; F Seitz; P Stokstad; G Mall; H Tillmanns; W Kübler
Journal:  Eur J Nucl Med       Date:  1992

9.  Fatty acid myocardial imaging using 123I-beta-methyl-iodophenyl pentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model).

Authors:  T Nishimura; M Sago; K Kihara; H Oka; T Shimonagata; T Katabuchi; M Hayashi; T Uehara; K Hayashida; H Noda
Journal:  Eur J Nucl Med       Date:  1989

10.  Impaired myocardial fatty acid metabolism detected by 123I-BMIPP in patients with unstable angina pectoris: comparison with perfusion imaging by 99mTc-sestamibi.

Authors:  Y Takeishi; H Sukekawa; H Saito; S Nishimura; T Shibu; Y Sasaki; H Tomoike
Journal:  Ann Nucl Med       Date:  1995-08       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.